SynthesisCurrent atherosclerosis reports2020

Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials.

Federica Fogacci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.